Therma Bright Inc. (TBRIF)
USD 0.02
(-1.41%)
USD 0.02
(-1.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 23.89 Thousand CAD | -82.86% |
| 2022 | 139.42 Thousand CAD | 3490.7% |
| 2021 | 3883.00 CAD | 2.64% |
| 2020 | 3783.00 CAD | -45.21% |
| 2019 | 6905.00 CAD | -51.01% |
| 2018 | 14.09 Thousand CAD | -54.77% |
| 2017 | 31.16 Thousand CAD | 550.18% |
| 2016 | 4793.00 CAD | 180.46% |
| 2015 | 1709.00 CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2009 | 172.75 Thousand CAD | -31.18% |
| 2008 | 251.01 Thousand CAD | 0.06% |
| 2007 | 250.85 Thousand CAD | -67.42% |
| 2006 | 770.02 Thousand CAD | 1657.66% |
| 2005 | 43.81 Thousand CAD | 13.69% |
| 2004 | 38.53 Thousand CAD | 1.86% |
| 2003 | 37.83 Thousand CAD | 481.85% |
| 2002 | 6502.00 CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6587.00 CAD | 0.86% |
| 2024 Q2 | 7795.00 CAD | 18.34% |
| 2024 Q3 | 4932.00 CAD | -36.73% |
| 2023 Q2 | 6543.00 CAD | 10.0% |
| 2023 Q1 | 5948.00 CAD | -95.33% |
| 2023 Q4 | 6531.00 CAD | 33.91% |
| 2023 FY | 23.89 Thousand CAD | -82.86% |
| 2023 Q3 | 4877.00 CAD | -25.46% |
| 2022 Q3 | 4752.00 CAD | -31.53% |
| 2022 Q2 | 6940.00 CAD | 2643.08% |
| 2022 Q1 | 253.00 CAD | -30.11% |
| 2022 FY | 139.42 Thousand CAD | 3490.7% |
| 2022 Q4 | 127.48 Thousand CAD | 2582.7% |
| 2021 Q4 | 362.00 CAD | -34.06% |
| 2021 Q3 | 549.00 CAD | -34.01% |
| 2021 Q1 | 2140.00 CAD | 283.51% |
| 2021 Q2 | 832.00 CAD | -61.12% |
| 2021 FY | 3883.00 CAD | 2.64% |
| 2020 Q2 | 990.00 CAD | -9.09% |
| 2020 Q3 | 1146.00 CAD | 15.76% |
| 2020 Q4 | 558.00 CAD | -51.31% |
| 2020 FY | 3783.00 CAD | -45.21% |
| 2020 Q1 | 1089.00 CAD | -50.21% |
| 2019 Q1 | 765.00 CAD | -89.22% |
| 2019 Q3 | 1571.00 CAD | -34.05% |
| 2019 FY | 6905.00 CAD | -51.01% |
| 2019 Q4 | 2187.00 CAD | 39.21% |
| 2019 Q2 | 2382.00 CAD | 211.37% |
| 2018 Q3 | 4712.00 CAD | 197.47% |
| 2018 Q4 | 7098.00 CAD | 50.64% |
| 2018 Q1 | 702.00 CAD | -97.51% |
| 2018 Q2 | 1584.00 CAD | 125.64% |
| 2018 FY | 14.09 Thousand CAD | -54.77% |
| 2017 Q3 | 392.00 CAD | -82.33% |
| 2017 FY | 31.16 Thousand CAD | 550.18% |
| 2017 Q4 | 28.15 Thousand CAD | 7082.65% |
| 2017 Q2 | 2219.00 CAD | 461.77% |
| 2017 Q1 | 395.00 CAD | -11.24% |
| 2016 Q1 | 783.00 CAD | -20.83% |
| 2016 FY | 4793.00 CAD | 180.46% |
| 2016 Q4 | 445.00 CAD | -76.9% |
| 2016 Q3 | 1926.00 CAD | 17.51% |
| 2016 Q2 | 1639.00 CAD | 109.32% |
| 2015 Q4 | 989.00 CAD | 74.43% |
| 2015 FY | 1709.00 CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | 153.00 CAD | 0.0% |
| 2015 Q3 | 567.00 CAD | 270.59% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | -100.0% |
| 2009 Q3 | 71.67 Thousand CAD | 523.88% |
| 2009 Q1 | 78.83 Thousand CAD | 42.81% |
| 2009 Q2 | 11.48 Thousand CAD | -85.43% |
| 2009 Q4 | 10.75 Thousand CAD | -85.0% |
| 2009 FY | 172.75 Thousand CAD | -31.18% |
| 2008 Q2 | 57.19 Thousand CAD | 94.88% |
| 2008 Q3 | 109.27 Thousand CAD | 91.04% |
| 2008 Q4 | 55.2 Thousand CAD | -49.48% |
| 2008 Q1 | 29.34 Thousand CAD | -65.1% |
| 2008 FY | 251.01 Thousand CAD | 0.06% |
| 2007 FY | 250.85 Thousand CAD | -67.42% |
| 2007 Q1 | 19.62 Thousand CAD | -77.29% |
| 2007 Q2 | 29.78 Thousand CAD | 51.76% |
| 2007 Q3 | 117.33 Thousand CAD | 293.91% |
| 2007 Q4 | 84.1 Thousand CAD | -28.32% |
| 2006 FY | 770.02 Thousand CAD | 1657.66% |
| 2006 Q2 | 5000.00 CAD | -83.97% |
| 2006 Q3 | 647.4 Thousand CAD | 12848.06% |
| 2006 Q4 | 86.42 Thousand CAD | -86.65% |
| 2006 Q1 | 31.2 Thousand CAD | 83.53% |
| 2005 FY | 43.81 Thousand CAD | 13.69% |
| 2005 Q1 | 7520.00 CAD | 0.0% |
| 2005 Q2 | 3040.00 CAD | -59.57% |
| 2005 Q3 | 16.25 Thousand CAD | 434.54% |
| 2005 Q4 | 17 Thousand CAD | 4.62% |
| 2004 Q3 | 6067.00 CAD | -63.23% |
| 2004 Q2 | 16.49 Thousand CAD | 31.56% |
| 2004 Q1 | 12.54 Thousand CAD | -31.7% |
| 2004 FY | 38.53 Thousand CAD | 1.86% |
| 2003 FY | 37.83 Thousand CAD | 481.85% |
| 2003 Q2 | 11.85 Thousand CAD | 27.63% |
| 2003 Q1 | 9288.00 CAD | -11.92% |
| 2003 Q4 | 18.36 Thousand CAD | 66.62% |
| 2003 Q3 | 11.01 Thousand CAD | -7.04% |
| 2002 Q2 | 2180.00 CAD | 0.0% |
| 2002 Q3 | 17.99 Thousand CAD | 725.64% |
| 2002 Q4 | 10.54 Thousand CAD | -41.41% |
| 2002 FY | 6502.00 CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AVITA Medical, Inc. | 50.56 Million USD | 99.953% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.997% |
| QHSLab, Inc. | 1.4 Million USD | 98.304% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 99.997% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 11.98 Million USD | 99.801% |
| Aurora Spine Corporation | 14.52 Million USD | 99.835% |
| BrainsWay Ltd. | 31.78 Million USD | 99.925% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | 96.656% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 99.965% |
| Vivos Inc. | 19.5 Thousand USD | -22.559% |
| Kelyniam Global, Inc. | 2.67 Million USD | 99.106% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | 88.269% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | 72.406% |
| Avitar, Inc. | 3.1 Million USD | 99.231% |
| Nanomix Corporation | 15.45 Thousand USD | -54.686% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 99.955% |
| Theraclion SA | 1.82 Million USD | 98.688% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 734.66 Thousand USD | 96.747% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 98.228% |
| Lombard Medical, Inc. | 12.16 Million USD | 99.804% |
| ALR Technologies Inc. | 7468.00 USD | -220.019% |
| Stratec SE | 289.14 Million USD | 99.992% |
| Vycor Medical, Inc. | 1.46 Million USD | 98.364% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 950.72 Million USD | 99.997% |
| VMS Rehab Systems, Inc. | 71.70 USD | -33231.939% |
| NewCardio, Inc. | 257.39 Thousand USD | 90.715% |
| Guided Therapeutics, Inc. | 98 Thousand USD | 75.613% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 96.684% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | 71.712% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 96.387% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 99.883% |
| IR-Med Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 94.078% |
| Polarean Imaging plc | 890.93 Thousand USD | 97.318% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 99.16% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 99.152% |
| Urologix, Inc. | 14.23 Million USD | 99.832% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 99.276% |
| SS Innovations International, Inc. | 5.87 Million USD | 99.594% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | 40.513% |
| Smith & Nephew plc | 5.68 Billion USD | 100.0% |
| NIOX Group Plc | 46.84 Million USD | 99.949% |
| Fuse Medical, Inc. | 16.11 Million USD | 99.852% |
| Broncus Holding Corporation | 10.25 Million USD | 99.767% |
| Brain Scientific Inc. | 214.56 Thousand USD | 88.862% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 98.792% |
| Health Logic Interactive Inc. | - USD | -Infinity% |